For research use only. Not for therapeutic Use.
Cifurtilimab（Cat No.:I042113）is an investigational monoclonal antibody designed to target and block the TIM-3 (T-cell immunoglobulin and mucin-domain containing-3) receptor, which plays a role in regulating immune responses. TIM-3 is often involved in suppressing immune activity in tumors, allowing cancer cells to evade detection and destruction. By inhibiting TIM-3, Cifurtilimab aims to enhance the immune system’s ability to recognize and attack cancer cells. It is being studied in clinical trials for the treatment of various cancers, including non-small cell lung cancer, and is often evaluated in combination with other immunotherapies.
| CAS Number | 1629760-27-5 |
| Purity | ≥95% |
